TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.70$ +50.4% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZYBT
Line item Q3 25 Q1 26
50.5% 50.1%
25.4% 25.4%
85.7% 82.2%
1.4% 1.4%
-22.1% -22.2%
0.0% –
-18.5% -17.1%
– 11.0%
49.1% 48.7%

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?